المؤلفون: Katherine L. Jones (2342800), Dominic M. Beaumont (11335330), Sharon G. Bernard (7571255), Rino A. Bit (1357536), Simon P. Campbell (11335333), Chun-wa Chung (1343454), Leanne Cutler (1738141), Emmanuel H. Demont (1399288), Kate Dennis (4707148), Laurie Gordon (1357524), James R. Gray (11335336), Michael V. Haase (2535787), Antonia J. Lewis (1738177), Scott McCleary (8232795), Darren J. Mitchell (1343451), Susanne M. Moore (11335339), Nigel Parr (449756), Olivia J. Robb (11335342), Nicholas Smithers (487233), Peter E. Soden (1926946), Colin J. Suckling (1268478), Simon Taylor (441637), Ann L. Walker (1738138), Robert J. Watson (1343463), Rab K. Prinjha (449759)

مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Computational Biology, Chemical Sciences not elsewhere classified, chemical series, Clinical Progression, I-BET 282E, toxicity findings, vivo tool molecule I-BET 151, property-based optimization, immuno-inflammatory areas, Novel Bromodomain, Protein Inhibitor, Extra Terminal Domain

Relation: https://figshare.com/articles/journal_contribution/Discovery_of_a_Novel_Bromodomain_and_Extra_Terminal_Domain_BET_Protein_Inhibitor_I_BET282E_Suitable_for_Clinical_Progression/16444258

الاتاحة: https://doi.org/10.1021/acs.jmedchem.1c00855.s001